GLLW
TEVA icon

Graves Light Lenhart Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Graves Light Lenhart Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$15K – 546
2022
Q2 		$15K Hold
2,000
– – ﹤0.01% 448
2022
Q1 		$19K Hold
2,000
– – ﹤0.01% 480
2021
Q4 		$16K Hold
2,000
– – ﹤0.01% 556
2021
Q3 		$19K Hold
2,000
– – ﹤0.01% 504
2021
Q2 		$20K Hold
2,000
– – ﹤0.01% 502
2021
Q1 		$23K Hold
2,000
– – ﹤0.01% 484
2020
Q4 		$19K Buy
+2,000
New +$19.2K ﹤0.01% 496

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Graves Light Lenhart Wealth's TEVA Position: Q3 2022 in Review

Graves Light Lenhart Wealth sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 2,000 shares — an estimated $15K sold.

Graves Light Lenhart Wealth first reported a position in TEVA in Q4 2020 and held it in 7 quarters. The position peaked at $23K in Q1 2021. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Graves Light Lenhart Wealth reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 2,000 Teva Pharmaceuticals shares in Q3 2022, an estimated $15K.
  • Graves Light Lenhart Wealth first reported a position in Teva Pharmaceuticals in Q4 2020 and held it in 7 quarters.
  • Graves Light Lenhart Wealth's Teva Pharmaceuticals position peaked at $23K in Q1 2021.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.